Dezhong Venturepharma is a pharmaceutical research and development module under the 4-O drive (Dezhong Venturepharma PDO, Sunshine Venturepharma CRO, Wante Manufacturing CMO, and Wandema Marketing CSO) of Wanquan China (China Medical Group HK8225). It was jointly established by China, the United States and Canada in 1997 and was founded by returned overseas students. It is an enterprise approved by the Beijing Administration for Industry and Commerce. The registered place is Changping Park, Zhongguancun Science and Technology Park, and the business scope belongs to the field of biomedicine. It has applied for thousands of patents, known as the “engine of China’s pharmaceutical industry”, and has a long-term cooperative relationship with more than 200 well-known enterprises at home and abroad. Eight global R&D centers, spanning four continents and six countries. The international R&D team has international talents from the United States, the United Kingdom, Japan, Australia, etc., and has established joint cooperation centers with many well-known universities at home and abroad. The registered capital is 30 million yuan, and the laboratory is located in Zhongguancun Life Science and Technology Park, with an area of 4000 m2. The company was established on April 13, 2012, its main business is the research and development of innovative drugs, the transfer and service of its own technology, the evaluation and service of drug efficacy/safety, the import and export of goods/technology, medical information consultation, etc. The Group company has been ranked first in the number of new drug applications in the State Food and Drug Administration (CFDA) for 11 consecutive years. The company with the group company with domestic and foreign colleges and universities, research institutes and many international and domestic pharmaceutical enterprises all-round, multi-level, different ways of cooperation to expand business. Venturepharma Dezhong implements a department-based, three-level management system. Under the company’s internal president, there are several major directly affiliated departments, including the Comprehensive Development Department (Medical Affairs Department), Project Management Department, Finance Department, Pharmacy and Clinical Department, Synthesis Department, Analysis Department, Preparation Department, Human Resources Department, Pharmacy Administration Department, Legal Affairs Department, Intellectual Property Management Center, and Marketing Department. The medical Affairs Department and Project Management department are responsible for the determination of research and development projects, referring to the opinions of other departments. The Project Management department, Synthesis department, analysis Department, formulation department, clinical Pharmacology department and intellectual property Management center are the main departments involved in drug research and development trials.